A Safety and Feasibility Study of Enteral Levetiracetam vs. Phenobarbital for Seizure Control in Pediatric Cerebral Malaria

Trial Profile

A Safety and Feasibility Study of Enteral Levetiracetam vs. Phenobarbital for Seizure Control in Pediatric Cerebral Malaria

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Aug 2016

At a glance

  • Drugs Levetiracetam (Primary) ; Phenobarbital
  • Indications Seizures
  • Focus Therapeutic Use
  • Acronyms LVT2
  • Most Recent Events

    • 21 Apr 2016 Results presented at the 68th Annual Meeting of the American Academy of Neurology
    • 19 Jun 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Jun 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top